To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Multicentre, randomised, … - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis

Journal article
Authors Oluf Andersen
I. Elovaara
M. Färkkilä
H.J. Hansen
S.I. Mellgren
K.-M. Myhr
M. Sandberg-Wollheim
P. Soelberg Sørensen
Published in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Volume 75
Issue 5
Pages 706-710
ISSN 0022-3050
Publication year 2004
Published at Institute of Clinical Neurosciences
Pages 706-710
Language en
Links dx.doi.org/10.1136/jnnp.2003.010090
Keywords controlled-trial, relapsing ms, beta-1a, pharmacokinetics, pharmacodynamics, therapy
Subject categories Neurology, Surgery, Psychiatry
Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?